Zimmer Biomet
1,005 hedge funds and large institutions have $21B invested in Zimmer Biomet in 2025 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 300 increasing their positions, 389 reducing their positions, and 100 closing their positions.
102% more call options, than puts
Call options by funds: $69.9M | Put options by funds: $34.6M
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
9% more capital invested
Capital invested by funds: $19.3B → $21B (+$1.69B)
1.34% more ownership
Funds ownership: 91.74% → 93.09% (+1.3%)
3% less funds holding
Funds holding: 1,031 → 1,005 (-26)
13% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 100
23% less repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 389
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$343M |
| 2 |
JP Morgan Chase
New York
|
+$163M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$95.7M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$69M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$60M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$132M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$101M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$78.9M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$71.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$51.6M |
ZBH Hedge Fund Activity: Q1 2025 in Review
1,005 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2025, worth a combined $21B — up 8.8% from $19.3B a quarter earlier.
Sellers outnumbered buyers: 100 funds closed out of ZBH and 87 opened new positions — a net loss of 13 holders — while 389 trimmed existing stakes and 300 added.
The largest buyer was Ameriprise, adding an estimated $343M. The largest seller was Fidelity Investments, cutting an estimated $132M.
- 1,005 institutional investors held Zimmer Biomet (ZBH) as of Q1 2025, down from 1,031 in Q4 2024.
- Funds reported $21B of Zimmer Biomet stock for Q1 2025, up 8.8% quarter-over-quarter.
- 87 funds opened new Zimmer Biomet positions in Q1 2025 and 100 closed out, a net change of -13 holders.
- The largest Zimmer Biomet buyer in Q1 2025 was Ameriprise, an estimated $343M added.
- The largest Zimmer Biomet seller in Q1 2025 was Fidelity Investments, an estimated $132M sold.
Based on aggregated 13F filings for Q1 2025.